EQUITY RESEARCH MEMO

Scilligence

Generated 5/14/2026

Executive Summary

Conviction (model self-assessment)60/100

Scilligence is a private US-based informatics company founded in 2009 that delivers an integrated software platform to streamline R&D workflows for life sciences organizations. Its core offerings include an Electronic Lab Notebook (ELN), a Registration & Assay Database (RegMol), Materials Inventory System, and Project Management Framework, all enhanced by AI/ML tools. The platform is designed by scientists for scientists, targeting both academic and industrial research teams to improve data management, collaboration, and experimental efficiency. Despite operating in a competitive landscape with players like Benchling and Dotmatics, Scilligence differentiates through its flexible, modular approach and scientific pedigree.

Upcoming Catalysts (preview)

  • Q3 2026Release of next-generation AI/ML-enhanced ELN module70% success
  • TBDStrategic partnership with a major pharmaceutical company50% success
  • TBDExpansion into clinical trial data management40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)